Asset Details
Do you wish to reserve the book?
CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease
Do you wish to request the book?
CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease
2018
Overview
Podocyte malfunction occurs in autoimmune and nonautoimmune kidney disease. Calcium signaling is essential for podocyte injury, but the role of Ca2+/calmodulin-dependent kinase (CaMK) signaling in podocytes has not been fully explored. We report that podocytes from patients with lupus nephritis and focal segmental glomerulosclerosis and lupus-prone and lipopolysaccharide- or adriamycin-treated mice display increased expression of CaMK IV (CaMK4), but not CaMK2. Mechanistically, CaMK4 modulated podocyte motility by altering the expression of the GTPases Rac1 and RhoA and suppressed the expression of nephrin, synaptopodin, and actin fibers in podocytes. In addition, it phosphorylated the scaffold protein 14-3-3β, which resulted in the release and degradation of synaptopodin. Targeted delivery of a CaMK4 inhibitor to podocytes preserved their ultrastructure, averted immune complex deposition and crescent formation, and suppressed proteinuria in lupus-prone mice and proteinuria in mice exposed to lipopolysaccharide-induced podocyte injury by preserving nephrin/synaptopodin expression. In animals exposed to adriamycin, podocyte-specific delivery of a CaMK4 inhibitor prevented and reversed podocyte injury and renal disease. We conclude that CaMK4 is pivotal in immune and nonimmune podocyte injury and that its targeted cell-specific inhibition preserves podocyte structure and function and should have therapeutic value in lupus nephritis and podocytopathies, including focal segmental glomerulosclerosis.
Publisher
American Society for Clinical Investigation
Subject
/ Analysis
/ Animals
/ Biopsy
/ Ca2+/calmodulin-dependent protein kinase
/ Calcium-Calmodulin-Dependent Protein Kinase Type 4 - immunology
/ Calcium-Calmodulin-Dependent Protein Kinase Type 4 - metabolism
/ Female
/ Glomerulosclerosis, Focal Segmental - enzymology
/ Glomerulosclerosis, Focal Segmental - immunology
/ Glomerulosclerosis, Focal Segmental - pathology
/ GTPases
/ Humans
/ Kidney Glomerulus - enzymology
/ Kidney Glomerulus - immunology
/ Kidney Glomerulus - pathology
/ Kidneys
/ Kinases
/ Lupus
/ Lupus Nephritis - enzymology
/ Lupus Nephritis - immunology
/ Male
/ Mice
/ Motility
/ Proteins
/ Rodents
/ Structure-function relationships
/ Trends
